dijous, 22 de gener del 2015

Opto Circuits' Eurocor wins CE Mark for drug-eluting stent




Eurocor, a subsidiary of India's Opto-Circuits, wins CE Mark approval in the European Union for its E-Magic Plus sirolimus-eluting coronary stent.






Eurocor said it gained CE Mark approval in the European Union for its new drug-eluting stent made with a biodegradable polymer.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1y2xomW

Cap comentari:

Publica un comentari a l'entrada